Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:19 AM
Ignite Modification Date:
2025-12-25 @ 4:19 AM
NCT ID:
NCT03445520
Eligibility Criteria:
Inclusion Criteria:
* Children:
* Transitioning into kindergarten or secondary school (middle/high school)
* Parent-rated SCQ total score \> 15 and AT LEAST one of the following:
* Positive ADOS-2 administered by research-reliable study personnel
* Expert medical diagnosis or educational classification of ASD
* Under-resourced, defined by:
* Attending or transitioning into a Title I school (a school that receives federal funding to improve the performance of economically disadvantaged students)or rural school
* Family income is under 250% of the federal guidelines for poverty rate (i.e., meets federal requirements to qualify for free or reduced lunch)
* Parent/Caregiver willing to participate
(Site PIs may request eligibility review by PIs across all AIR-B sites if a school is not Title I or rural but is demonstrably low-resource)
Adults:
* Must be a parent/caregiver of a child who meets criteria above
* Must be a provider/teacher/school administrator or other adult involved in either the pre-transition process or the post transition process for a participating child.
Exclusion Criteria:
* Children:
* Not transitioning into kindergarten or secondary school
* No ASD diagnosis
* Not meeting study criteria for classification as under-resourced
* Parent/Caregiver unwilling to participate
Adults:
* Not a parent/guardian of a child with ASD
* Not part of a participating child with ASD's pre or post transition team
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03445520
Study Brief:
Protocol Section:
NCT03445520